Trials / Completed
CompletedNCT01062529
Peripheral Metabolic Effects of Somatostatin
Peripheral Metabolic Effects of Intra Arterial Somatostatin Infusion in Healthy Controls
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to investigate peripheral effects of Somatostatin on glucose metabolism and growth hormone (GH) signalling in healthy men. Eight subjects will be enrolled. The hypothesis is that Somatostatin infusion reverses insulin resistance caused by GH.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Somatostatin | 4 h of 150 microgram infusion |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2010-02-01
- Completion
- 2010-02-01
- First posted
- 2010-02-04
- Last updated
- 2013-01-21
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01062529. Inclusion in this directory is not an endorsement.